← Eichor
Study identifier: NCT07628998 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of SMS Messaging on Participation in Colorectal Cancer Screening

Condition: Colorectal Neoplasms · Early Detection of Cancer  ·  Sponsor: Corporacion Parc Tauli

PhaseNA
Planned participants10084
Who can joinAll sexes, 50 Years to 69 Years
Healthy volunteersYes

About this study

Colorectal cancer is a leading cause of mortality in Catalonia. Although early detection programs using the fecal immunochemical test (FIT) are effective in reducing both incidence and mortality, their success relies on high population participation. Currently, in the Vallès Occidental region, the participation rate stands at 42%, which is below the 65% minimum recommended by European health authorities. The objective of this randomized controlled trial is to evaluate whether sending a reminder text message (SMS) is an effective tool to increase participation in the screening program. The study will include 10,084 participants aged between 50 and 69 years. Half of the participants will receive a reminder SMS five weeks after their initial invitation, while the other half will follow the standard of care involving postal letters. Researchers anticipate that this strategy will not only increase the number of individuals undergoing screening but also shorten the response time and reduce the need for sending postal reminders

This description comes directly from the study's public registry record.

Talk to the study team

Anna Selva Olid, PhD  ·  +34937231010  ·  aselva@tauli.cat

Marina Lleal Custey, PhD  ·  +34937231010  ·  mlleal@tauli.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Unitat de Cribratge de Cáncer, Consorci Corporació Sanitaria Parc TaulíSabadell, Catalonia, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07628998